Quest for the right Drug

|
עמוד הבית / אנסטילר / מידע מעלון לרופא

אנסטילר ENSTILAR (BETAMETHASONE AS DIPROPIONATE, CALCIPOTRIOL AS MONOHYDRATE)

תרופה במרשם תרופה בסל נרקוטיקה ציטוטוקסיקה

צורת מתן:

חיצוני : TOPICAL

צורת מינון:

קצף לעור : CUTANEOUS FOAM

Posology : מינונים

4.2 Posology and method of administration

Posology
Enstilar foam should be applied to the affected area once daily. The recommended treatment period is 4 weeks. The daily maximum dose of Enstilar should not exceed 15 g, i.e. one 60 g can should last for at least 4 days of treatment. 15 g corresponds to the amount administered from the can if the actuator is fully depressed for approximately one minute. A two-second application delivers approximately 0.5 g. As a guide, 0.5 g of foam should cover an area of skin roughly corresponding to the surface area of an adult hand.
If using other topical products containing calcipotriol in addition to Enstilar, the total dose of all calcipotriol containing products should not exceed 15 g per day.
The total body surface area treated should not exceed 30%.

Special populations
Renal and hepatic impairment
The safety and efficacy of Enstilar foam in patients with severe renal insufficiency or severe hepatic disorders have not been evaluated.

Paediatric population
The safety and efficacy of Enstilar foam in children below 18 years have not been established. Enstilar is not indicated for children below 18 years of age.

Method of administration
For cutaneous use.
The can should be shaken for a few seconds before use. Enstilar should be applied by spraying holding the can at least 3 cm from the skin. The foam can be sprayed holding the can in any orientation except horizontally.
Enstilar should be sprayed directly onto each affected skin area and rubbed in gently.
If used on the scalp, Enstilar should be sprayed into the palm of the hand and then applied to affected scalp areas with the fingertips. Hair washing instructions are provided in the package leaflet.
The hands should be washed after using Enstilar (unless Enstilar is used to treat the hands) to avoid accidentally spreading to other parts of the body. Application under occlusive dressings should be avoided since it increases the systemic absorption of corticosteroids. It is recommended not to take a shower or bath immediately after application of Enstilar. Let the foam remain on the scalp and/or skin during the night or during the day.

שימוש לפי פנקס קופ''ח כללית 1994 לא צוין
תאריך הכללה מקורי בסל 03/01/2010
הגבלות תרופה מוגבלת לרישום ע'י רופא מומחה או הגבלה אחרת

בעל רישום

DEXCEL LTD, ISRAEL

רישום

163 91 35848 01

מחיר

0 ₪

מידע נוסף

עלון מידע לרופא

19.07.21 - עלון לרופא 05.12.22 - עלון לרופא

עלון מידע לצרכן

10.08.21 - עלון לצרכן אנגלית 10.08.21 - עלון לצרכן עברית 10.08.21 - עלון לצרכן ערבית 05.12.22 - עלון לצרכן עברית 11.05.23 - עלון לצרכן אנגלית 11.05.23 - עלון לצרכן ערבית 12.01.21 - החמרה לעלון 05.12.22 - החמרה לעלון

לתרופה במאגר משרד הבריאות

אנסטילר

קישורים נוספים

RxList WebMD Drugs.com